[
  {
    "ts": null,
    "headline": "Amgen Inc. stock underperforms Wednesday when compared to competitors",
    "summary": "Amgen Inc. stock underperforms Wednesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=b92beb8fa2b7745c43bbc3d9eb2bba39b42a5eb6de53b20eb54886f70ecfa410",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747845360,
      "headline": "Amgen Inc. stock underperforms Wednesday when compared to competitors",
      "id": 134635068,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Amgen Inc. stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=b92beb8fa2b7745c43bbc3d9eb2bba39b42a5eb6de53b20eb54886f70ecfa410"
    }
  },
  {
    "ts": null,
    "headline": "AMGN Down 10% in 3 Months: How to Play the Stock as Tariff Woes Linger",
    "summary": "AMGN's consistent top-line growth, an interesting pipeline and rising estimates are good enough reasons to stay invested in the stock for now.",
    "url": "https://finnhub.io/api/news?id=9d2f626961cd8cc71812039340b404b442b5439b3f5139eba95edeeb1df4f3ea",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747831800,
      "headline": "AMGN Down 10% in 3 Months: How to Play the Stock as Tariff Woes Linger",
      "id": 134628486,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "AMGN's consistent top-line growth, an interesting pipeline and rising estimates are good enough reasons to stay invested in the stock for now.",
      "url": "https://finnhub.io/api/news?id=9d2f626961cd8cc71812039340b404b442b5439b3f5139eba95edeeb1df4f3ea"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Inc. (AMGN) RBC Capital Markets Global Healthcare Conference (Transcript)",
    "summary": "Amgen Inc. (NASDAQ:AMGN) RBC Capital Markets Global Healthcare Conference May 21, 2025 9:00 AM ETCompany ParticipantsJustin Claeys - VP, IRKave Niksefat -...",
    "url": "https://finnhub.io/api/news?id=ee04b085663f97d8318027a222a1ae53ae38d3ba53dff15a671ebea9507f54d2",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747827125,
      "headline": "Amgen Inc. (AMGN) RBC Capital Markets Global Healthcare Conference (Transcript)",
      "id": 134626266,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Amgen Inc. (NASDAQ:AMGN) RBC Capital Markets Global Healthcare Conference May 21, 2025 9:00 AM ETCompany ParticipantsJustin Claeys - VP, IRKave Niksefat -...",
      "url": "https://finnhub.io/api/news?id=ee04b085663f97d8318027a222a1ae53ae38d3ba53dff15a671ebea9507f54d2"
    }
  },
  {
    "ts": null,
    "headline": "Viridian Therapeutics’ veligrotug shows durability in Phase III TED trial",
    "summary": "Viridian will be submitting a biologics licence application to the FDA later this year.",
    "url": "https://finnhub.io/api/news?id=52b5fb58a261231bb9746c91ffcbab0a5f5e93ca999cf0099435e1e16e9893a9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747825382,
      "headline": "Viridian Therapeutics’ veligrotug shows durability in Phase III TED trial",
      "id": 134628487,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Viridian will be submitting a biologics licence application to the FDA later this year.",
      "url": "https://finnhub.io/api/news?id=52b5fb58a261231bb9746c91ffcbab0a5f5e93ca999cf0099435e1e16e9893a9"
    }
  },
  {
    "ts": null,
    "headline": "Transcript : Amgen Inc. Presents at RBC Capital Markets Global Healthcare Conference 2025, May-21-2025 09",
    "summary": "Presenter SpeechGregory Renza [Audio Gap] Global Healthcare Conference. My name is Greg Renza, one of the Biotech Equity Research Analyst here, and we're pleased to be joined now by Amgen. And",
    "url": "https://finnhub.io/api/news?id=264d53575ed21aed48e51a49b616c6b0b04ab39b8588a3e331d88efc4da6e996",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747821926,
      "headline": "Transcript : Amgen Inc. Presents at RBC Capital Markets Global Healthcare Conference 2025, May-21-2025 09",
      "id": 134625550,
      "image": "",
      "related": "AMGN",
      "source": "Finnhub",
      "summary": "Presenter SpeechGregory Renza [Audio Gap] Global Healthcare Conference. My name is Greg Renza, one of the Biotech Equity Research Analyst here, and we're pleased to be joined now by Amgen. And",
      "url": "https://finnhub.io/api/news?id=264d53575ed21aed48e51a49b616c6b0b04ab39b8588a3e331d88efc4da6e996"
    }
  }
]